Symbols / ALLG
ALLG Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Cyclosporin/Cyclophosphamide Is a Potential New SOC in GVHD Management - CancerNetwork ue, 17 Jun 2025 07
- Allego N.V. Announces Voluntarily Delisting from the New York Stock Exchange - Stock Titan Fri, 02 Aug 2024 07
- Allego (ALLG) Stock Price, News & Analysis $ALLG - MarketBeat Sun, 20 Mar 2022 09
- Allego delists from the US stock exchange under Meridiam’s management - electrive.com ue, 06 Aug 2024 07
- ALLG - Allego N.V. Latest Stock News & Market Updates - Stock Titan hu, 17 Mar 2022 11
- AAN Stock Alert: The Aaron’s Company Pops 33% on Take-Private Deal - InvestorPlace Mon, 17 Jun 2024 07
- Portfolio Jolt: 3 Under-the-Radar EV Charging Stocks Set for 100% Gains - Yahoo Finance ue, 12 Sep 2023 07
- 3 Best EV Charging Stocks for High Returns - Nasdaq hu, 02 Nov 2023 07
- Allego and Meridiam Jointly Announce Expiration and Final Results of Tender Offer - Business Wire hu, 01 Aug 2024 07
- Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial - The Lancet hu, 20 Aug 2015 07
- Nuclear Power in the Netherlands - World Nuclear Association Wed, 01 May 2024 11
- Allego Holding B.V. completed the acquisition of SPARTAN Acquisition CORP. III from Spartan Acquisition Sponsor III LLC, Citadel Advisors LLC and others in a reverse merger transaction. - marketscreener.com ue, 15 Mar 2022 07
- Funding and M&A Roundup: Shell to Buy Residential Renewables Retailer Inspire Energy - Mercom Capital Group Mon, 02 Aug 2021 07
- Why Is Ovid Therapeutics (OVID) Stock Down 69% Today? - InvestorPlace Mon, 17 Jun 2024 07
- Spartan Acquisition Corp. III and Allego Holding B.V. Complete Business Combination to Establish NYSE-Listed pan-European Electric Vehicle Charging Network - Business Wire Wed, 16 Mar 2022 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for ALLG
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|